Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-10-19
DOI
10.3389/fphys.2016.00472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function
- (2016) Lena Pernas et al. Annual Review of Physiology
- Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting
- (2016) Stephanie T. Isaac et al. CURRENT DRUG TARGETS
- Chemotherapy-Related Neurotoxicity
- (2016) Sophie Taillibert et al. Current Neurology and Neuroscience Reports
- The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting
- (2016) James A. Carson et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
- (2016) Rafael Barreto et al. Oncotarget
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Muscle wasting in cancer
- (2015) Josep M. Argilés et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Excess TGF-β mediates muscle weakness associated with bone metastases in mice
- (2015) David L Waning et al. NATURE MEDICINE
- Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action
- (2015) Vikas Dutt et al. PHARMACOLOGICAL RESEARCH
- Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
- (2015) Fabrizio Pin et al. Oncotarget
- Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia
- (2015) Julie B. McLean et al. Frontiers in Physiology
- Cancer cachexia, mechanism and treatment
- (2015) Tomoyoshi Aoyagi et al. World Journal of Gastrointestinal Oncology
- Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
- (2014) Guro B. Stene et al. ACTA ONCOLOGICA
- Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
- (2014) Hee-Won Jung et al. SUPPORTIVE CARE IN CANCER
- Inflammation Based Regulation of Cancer Cachexia
- (2014) Jill K. Onesti et al. Biomed Research International
- Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice
- (2013) Jose M. Garcia et al. ENDOCRINOLOGY
- JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
- (2012) Andrea Bonetto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?
- (2012) Cibely Cristine Fontes-Oliveira et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A statistical model-building perspective to identification of MS/MS spectra with PeptideProphet
- (2012) Kelvin Ma et al. BMC BIOINFORMATICS
- Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- (2012) Kenneth C.H. Fearon et al. Cell Metabolism
- Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results
- (2012) Lene Thoresen et al. CLINICAL NUTRITION
- Genomic and Proteomic Profiling Reveals Reduced Mitochondrial Function and Disruption of the Neuromuscular Junction Driving Rat Sarcopenia
- (2012) C. Ibebunjo et al. MOLECULAR AND CELLULAR BIOLOGY
- 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
- (2011) Pierre-Yves Cordier et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity
- (2011) Carla MM Prado et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- A Novel Alignment Method and Multiple Filters for Exclusion of Unqualified Peptides To Enhance Label-Free Quantification Using Peptide Intensity in LC–MS/MS
- (2011) Xianyin Lai et al. JOURNAL OF PROTEOME RESEARCH
- STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
- (2011) Andrea Bonetto et al. PLoS One
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity
- (2010) F. Montagnani et al. Colorectal Disease
- Contribution of anorexia to tissue wasting in cachexia
- (2010) Alessio Molfino et al. Current Opinion in Supportive and Palliative Care
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
- (2009) A. Bonetto et al. CURRENT CANCER DRUG TARGETS
- MASIC: A software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC–MS(/MS) features
- (2008) Matthew E. Monroe et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and Cachexia
- (2007) José M. Garcia et al. ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More